These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 7622813
1. Safety and tolerance profile of venlafaxine. Danjou P, Hackett D. Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():15-20. PubMed ID: 7622813 [Abstract] [Full Text] [Related]
2. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. Shrivastava RK, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J, Kiev A, Patrick R. J Clin Psychopharmacol; 1994 Oct; 14(5):322-9. PubMed ID: 7806687 [Abstract] [Full Text] [Related]
3. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. Rudolph RL, Fabre LF, Feighner JP, Rickels K, Entsuah R, Derivan AT. J Clin Psychiatry; 1998 Mar; 59(3):116-22. PubMed ID: 9541154 [Abstract] [Full Text] [Related]
4. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group. Khan A, Upton GV, Rudolph RL, Entsuah R, Leventer SM. J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838 [Abstract] [Full Text] [Related]
5. Rapid onset of action of venlafaxine. Montgomery SA. Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814 [Abstract] [Full Text] [Related]
6. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. Rudolph RL, Derivan AT. J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):54S-59S; discussion 59S-61S. PubMed ID: 8784648 [Abstract] [Full Text] [Related]
7. A meta-analysis of the effects of venlafaxine on anxiety associated with depression. Rudolph RL, Entsuah R, Chitra R. J Clin Psychopharmacol; 1998 Apr; 18(2):136-44. PubMed ID: 9555599 [Abstract] [Full Text] [Related]
10. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression. Samuelian JC, Hackett D. J Psychopharmacol; 1998 Apr; 12(3):273-8. PubMed ID: 10958254 [Abstract] [Full Text] [Related]
11. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group. Thase ME. J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690 [Abstract] [Full Text] [Related]
13. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Clerc GE, Ruimy P, Verdeau-Pallès J. Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822 [Abstract] [Full Text] [Related]
15. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis. van den Broek WW, Mulder PG, van Os E, Birkenhäger TK, Pluijms E, Bruijn JA. J Psychopharmacol; 2009 Aug; 23(6):708-13. PubMed ID: 18562424 [Abstract] [Full Text] [Related]
18. Therapeutic options for treating major depression, and the role of venlafaxine. Scott MA, Shelton PS, Gattis W. Pharmacotherapy; 1996 May; 16(3):352-65. PubMed ID: 8726593 [Abstract] [Full Text] [Related]